 |
Articles: General Pharma |
Prior Articles
Cisco and Karos unveil info-sharing technology
Canadian Healthcare Technology, 06/26/09
Free full text
Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials: systematic literature review
Current Medical Research and Opinion, 06/26/09 ONGLYZA (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
Bristol Myers-Squibb Company, 06/26/09
Free full text
eHealth Ontario CEO, Sarah Kramer, is terminated
Canadian Healthcare Technology, 06/26/09
Free full text
Antigenics' QS-21 Adjuvant Enters Pivotal Phase 3 Clinical Trial of GlaxoSmithKline's Malaria Vaccine
Antigenics, 06/26/09
Free full text
Trillium chooses Salumatics for records conversion
Canadian Healthcare Technology, 06/26/09
Free full text
Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial
Active Biotech, 06/26/09
Free full text
Horizon inks distribution agreement with Sedecal
Canadian Healthcare Technology, 06/26/09
Free full text
CHIEF created for health IT execs
Canadian Healthcare Technology, 06/26/09
Free full text
Sandoz receives approval for first-ever Japanese biosimilar
Novartis, 06/26/09
Free full text
Inergy automotive systems brings two innovations which are reducing environmental impact of cars
Solvay, 06/26/09
Free full text
Alliances Boost Hospital Vendor's Wares
HealthDataManagement, 06/26/09 NPS Pharmaceuticals President and CEO Dr. Francois Nader Recognized By Ernst and Young as 2009 Entrepreneur of the Year Finalist in New Jersey
NPS Pharmaceuticals, 06/25/09
Free full text
Phase I Trial of Pazopanib in Patients with Advanced Cancer
Clinical Cancer Research, 06/25/09 Recent developments in the use of oral anticoagulants
Expert Opinion in Pharmacotherapy, 06/25/09 Study Shows Medtronic Microdebrider Turbinoplasty Is a Significantly More Effective, Long-Term Treatment than Coblation Radiofrequency for Nasal Obstructions
Medtronic, 06/25/09
Free full text
Afinitor and Sandostatin LAR Phase II data show advanced pancreatic NET patients remain progression-free for nearly 17 months
Novartis, 06/25/09
Free full text
Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
Cell Therapeutics, 06/25/09
Free full text
The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials
Current Medical Research and Opinion, 06/25/09 A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression
Journal of Acquired Immune Deficiency Syndromes, 06/25/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
